187 related articles for article (PubMed ID: 3581059)
1. Correlation of thyroid hormone dose-dependent regulation of K-ras protooncogene expression with oncogene activation by 3-methylcholanthrene: loss of thyroidal regulation in the transformed mouse cell.
Guernsey DL; Leuthauser SW
Cancer Res; 1987 Jun; 47(12):3052-6. PubMed ID: 3581059
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
5. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
Fernandes ER; Ashendel CL
Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
[TBL] [Abstract][Full Text] [Related]
6. Increased messenger RNA levels of the antagonist thyroid hormone receptor erbA-alpha 2 and decreased levels of erbA-alpha 1 and erbA-beta 1 receptor messenger RNAs in neoplastic rodent cells.
Too CK; Guernsey DL
Cancer Res; 1992 Apr; 52(8):2186-90. PubMed ID: 1559222
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
9. Regulation of anchorage-independent growth by thyroid hormone in type 5 adenovirus-transformed rat embryo cells.
Babiss LE; Guernsey DL; Fisher PB
Cancer Res; 1985 Dec; 45(12 Pt 1):6017-23. PubMed ID: 3877564
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone and neoplastic transformation.
Guernsey DL; Fisher PB
Crit Rev Oncog; 1990; 1(4):389-408. PubMed ID: 1982076
[No Abstract] [Full Text] [Related]
11. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
13. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.
Sap J; Muñoz A; Schmitt J; Stunnenberg H; Vennström B
Nature; 1989 Jul; 340(6230):242-4. PubMed ID: 2569164
[TBL] [Abstract][Full Text] [Related]
14. Genomic rearrangements in mouse C3H/10T1/2 cells transformed by X-rays, UV-C, and 3-methylcholanthrene, detected by a DNA fingerprint assay.
Paquette B; Little JB
Cancer Res; 1992 Oct; 52(20):5788-93. PubMed ID: 1327516
[TBL] [Abstract][Full Text] [Related]
15. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
16. Anisomycin abrogates repression of protooncogene c-fos transcription in E1A + cHa-ras-transformed cells through activation of MEK/ERK kinase cascade.
Kukushkin AN; Svetlikova SB; Amanzholov RA; Pospelov VA
J Cell Biochem; 2008 Feb; 103(3):1005-12. PubMed ID: 17647273
[TBL] [Abstract][Full Text] [Related]
17. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah K; Telang N; Ramonetti JT; Araki R; DeVito B; Weksler BB; Dannenberg AJ
Cancer Res; 1996 Oct; 56(19):4424-9. PubMed ID: 8813136
[TBL] [Abstract][Full Text] [Related]
18. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
[TBL] [Abstract][Full Text] [Related]
19. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells.
Ivan M; Bond JA; Prat M; Comoglio PM; Wynford-Thomas D
Oncogene; 1997 May; 14(20):2417-23. PubMed ID: 9188856
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
